SENSEX NIFTY
Natco Pharma

News from other websites on Natco Pharma

Natco clears legal hurdles for launch of Copaxone generic in US

Jul 27, 2013 at 18:07 | Source: The Hindu BusinessLine

Natco Pharma Ltd has been awarded a favourable judgement in the US Court of Appeals for the Federal Circuit ruling on a patent related to Teva’s Copaxone. The court of appeals had reversed a district court’s finding related to the Copaxo...

Sensex ends 114 pts down; Jindal Steel, ONGC, Maruti losers

Jul 02, 2013 at 22:52 | Source: DomainB

4:00 pm Market closing: It was a weak session on Dalal Street. The Sensex ended 113.57 points down at 19463.82, and the Nifty closed at 5857.55, down 41.30 points. 3:40 pm Losers: Jindal Steel , ONGC , Maruti Suzuki, Infosys and Tata Power are loser...

Khoj-Tate in landmark collaboration

Jun 26, 2013 at 11:06 | Source: DNA India

Khoj, the New Delhi-based experimental art studio, is going places. Come July 12 and the Tate Modern in London, Britain s and perhaps the world s foremost art gallery, will open a group exhibition that has been conceptualised as a curatorial collabo...

Uttarakhand: 4 more bodies recovered from chopper crash site, toll reaches 12

Jun 26, 2013 at 11:06 | Source: DNA India

Four more bodies were recovered by IAF commandos near Gaurikund in Uttarakhand where an IAF Mi-17 helicopter carrying 20 people had crashed during a rescue mission and all onboard are feared killed. During night-long search operations, Garud command...

Rupee down 12 paise against dollar in early trade

Jun 26, 2013 at 11:00 | Source: DNA India

The rupee today fell by 12 paise to 59.78 against the dollar in early trade on the Interbank Foreign Exchange market on increased demand for the US currency from importers. A firm opening in the domestic equity market and easing dollar against other...

Indian rupee down 12 paise Vs dollar in early trade

Jun 26, 2013 at 10:46 | Source: Business Today

Increased demand for the US currency from importers led the Indian rupee fall by 12 paise to 59.78 against the dollar in early trade on Wednesday on the Interbank Foreign Exchange market.Forex dealers said a firm opening in the domestic equity marke...

Sensex shrugs off RBI policy; rallies 148 ahead of Fed meet

Jun 17, 2013 at 23:27 | Source: DomainB

Equity benchmarks gained momentum in late trade Monday ahead Federal Reserve's meeting, ignoring RBI's status quo credit policy . BSE Sensex rose 147.94 points or 0.77 percent to close at 19325.87, and NSE Nifty gained 43.10 points or 0.74 percent a...

India needs to show the world it respects intellectual property rights: Kiran Mazumdar-Shaw

Jun 10, 2013 at 15:56 | Source: Economic Times

NEW DELHI: India needs to show the world that it respects intellectual property rights if it wants global pharmaceutical firms to invest in India, according to Biocon Chairman and Managing Director Kiran Mazumdar-Shaw. She also said India should be ...

How Big Pharma-designed cacophony against Ranbaxy drowns vital voices

Jun 10, 2013 at 15:54 | Source: FirstPost

In the unresisted and rapidly rising cacophony against the FDA-tainted Ranbaxy, what get drowned unfortunately are voices that are vital to the countrys drug industry and peoples health.Ranbaxy in the eyes of FDA (Food and Drug Administration) is cer...

Pharmaceutical exports slow down due to approval delays and recalls

Jun 06, 2013 at 06:00 | Source: Economic Times

HYDERABAD: India's pharmaceutical exports grew at less than half the pace it did last year, hurt by delays in drug approvals and products recalls in some of its key markets. In dollar terms, pharmaceutical exports rose 9.9% in fiscal 2013, compared ...

Tax charge pulls Natco Pharma net down by 19%

May 30, 2013 at 23:07 | Source: The Hindu BusinessLine

Hyderabad, May 30: Natco Pharma Ltd’s standalone net profit decreased 19.3 per cent at Rs 11.72 crore in the fourth quarter ended March 31, 2013 compared to Rs 14.53 crore in the same period last year. The revenue of the Hyderabad-based compan...

Sensex ends up ahead of Q4 GDP data; Tata Motors, M&M lead

May 30, 2013 at 20:12 | Source: DomainB

Equity benchmarks finished higher Thursday after trading in a narrow range for most part of the day. Dealers attributed the late spike to squaring of short positions in the derivatives segment, today being the settlement day for May series. The BSE ...

Dr Reddy’s says ‘have factored in the impact’

May 18, 2013 at 00:17 | Source: The Hindu BusinessLine

Hyderabad, May 17: Pharma major Dr Reddy’s Laboratories Ltd said the new pricing policy might impact 3-4 per cent of its finished dosage sales in the domestic market. The Department of Pharmaceuticals had notified the Drug Prices Control Order...

Novartis patent row: US 'concerned' over India's patent norms, innovation

May 02, 2013 at 15:04 | Source: FirstPost

Washington: Raising questions over innovation climate in India, the US has said the recent decision by India's Supreme Court to prohibit patent of Novartis' cancer drug Glivec could "preclude issuance of a patent" in the country.In its '201...

Launch of patented drugs could be delayed in India. Here's why

May 02, 2013 at 14:08 | Source: FirstPost

Launch of patented drugs in India could be delayed due to the government's "thought process on linking patented drug prices to the country's per-capita income", according to a report by consultancy firm Deloitte."The recent government ...

Patented drug entry could be delayed in India: Deloitte

May 01, 2013 at 19:07 | Source: The Hindu BusinessLine

New Delhi, May 1: Launch of patented drugs in India could be delayed due to the government’s “thought process on linking patented drug prices to the country’s per—capita income”, according to a report by consultancy fir...

In the ‘pharmacy of the world’

Apr 29, 2013 at 00:51 | Source: The Hindu BusinessLine

Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy’s key architect and...

Andhra Pradesh: From bulk drugs to affordable medicines, vaccines

Apr 29, 2013 at 00:51 | Source: The Hindu BusinessLine

“In Hyderabad, entrepreneurs are driven by a herd mentality. If there is one successful venture, a dozen will follow. The high number of bulk drug manufacturers in a way is just manifestation of such a trend”. Habil Khorakiwala, Chairman...

Don’t overdose on MNC pharma stocks

Apr 27, 2013 at 23:46 | Source: The Hindu BusinessLine

Investors, buffeted by the wild swings in stock markets in the last five years, have sought refuge in stocks of ‘defensive’ pharma companies. After all, drug sales aren’t particularly affected by an economic slowdown. Select multin...

Only 3% of patents filed by MNC pharma firms under dispute: Study

Apr 16, 2013 at 06:20 | Source: Economic Times

MUMBAI: On April 1, when the Supreme Court rejected Swiss pharmaceutical major Novartis' plea for a patent on an updated version of its cancer drug Glivec, it evoked different reactions: Big Pharma cried foul terming the ruling as one that "discoura...

video of the day

See Sensex at 30K by Aug; like autos, banks: Nomura

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.